Thai migraine patients share Real-World treatment hurdles
NCT ID NCT07035197
First seen Apr 14, 2026 · Last updated Jun 13, 2026 · Updated 9 times
Summary
This study looked at the real-life experiences of 30 people with migraine and their healthcare providers in Thailand who used a new preventive medicine called eptinezumab. The goal was to find out what makes it easier or harder to use this treatment in a hospital setting. Participants shared their thoughts through interviews and questionnaires over 6 months. The results may help improve access to migraine care in middle-income countries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
King Chualongkorn Memorial Hospital, the Thai Red Cross Society
Bangkok, 10330, Thailand
Conditions
Explore the condition pages connected to this study.